91����

In fiscal year 2023 — Oct. 1–Sept. 30, 2023 — 91���� was awarded more than $8 million in technology maturation funding through the Department of Energy’s Technology Commercialization Fund, or TCF.

Scientist-inventors from ORNL will present seven new technologies during the Technology Innovation Showcase on Friday, July 14, from 8 a.m.–4 p.m. at the Joint Institute for Computational Sciences on ORNL’s campus.

Scientists at ORNL developed a competitive, eco-friendly alternative made without harmful blowing agents.

Researchers at ORNL explored radium’s chemistry to advance cancer treatments using ionizing radiation.

Five technologies invented by scientists at the Department of Energy’s 91���� have been selected for targeted investment through ORNL’s Technology Innovation Program.

Researchers at the Department of Energy’s 91���� and their technologies have received seven 2022 R&D 100 Awards, plus special recognition for a battery-related green technology product.

ORNL scientists will present new technologies available for licensing during the annual Technology Innovation Showcase. The event is 9 a.m. to 3 p.m. Thursday, June 16, at the Manufacturing Demonstration Facility at ORNL’s Hardin Valley campus.

In the race to identify solutions to the COVID-19 pandemic, researchers at the Department of Energy’s 91���� are joining the fight by applying expertise in computational science, advanced manufacturing, data science and neutron science.

The Department of Energy’s 91���� is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.

“Made in the USA.” That can now be said of the radioactive isotope molybdenum-99 (Mo-99), last made in the United States in the late 1980s. Its short-lived decay product, technetium-99m (Tc-99m), is the most widely used radioisotope in medical diagnostic imaging. Tc-99m is best known ...